文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

水凝胶间隔物直肠壁浸润深度与直肠毒性无关:一项随机前瞻性试验结果

Depth of Hydrogel Spacer Rectal Wall Infiltration Was Not Associated With Rectal Toxicity: Results From a Randomized Prospective Trial.
PubMed 文献 · Adv Radiat Oncol · 2024-09-11

基于149例随机分入水凝胶间隔物组的前列腺癌放疗患者植入后T2加权MRI,按0-3分评估直肠壁浸润深度。24%存在影像学直肠壁浸润(2分20.1%、3分4.0%),全层浸润与更长浸润长度(22.8±7.0 mm,P=.008)和更大环周百分比(35.8%±9.2%,P=.045)相关。直肠壁浸润与操作性、急性或晚期直肠毒性均无相关性,6例3分者至15个月均未发生晚期直肠毒性。

要点

  • 24%水凝胶间隔物植入者MRI可见直肠壁浸润(2分20.1%、3分4.0%)
  • 全层浸润者浸润长度22.8±7.0 mm、环周百分比35.8%±9.2%
  • 直肠壁浸润与操作性、急性及晚期直肠毒性均无相关性

核心结论

  • 基于随机对照试验数据,直肠壁浸润未导致常规前列腺癌放疗前及放疗后至15个月直肠毒性增加。

研究设计与样本

  • 研究评估已发表多中心随机对照试验中随机分入水凝胶间隔物组的149例受试者植入后T2加权磁共振图像。

主要发现

  • 62.4%植入物无直肠壁信号异常,24%手术有直肠壁浸润影像学证据(2分20.1%、3分4.0%)。
  • 全层直肠壁浸润与更长浸润长度(22.8±7.0 mm,P=.008)和更大环周百分比(35.8%±9.2%,P=.045)相关。
  • 7例(5%)受试者发生一过性操作相关直肠毒性,最常见为会阴/直肠疼痛,其中仅1例有直肠壁浸润(2分,美国国家癌症研究所不良事件通用术语标准1级)。
  • 操作性直肠毒性与直肠壁浸润存在/范围无相关性(P=.64)。
  • 直肠壁浸润各分类间急性(P=.64)或晚期(P=.85)直肠毒性发生率或分级无差异;6例直肠壁浸润评分为3分的男性至15个月均未发生晚期直肠毒性。

关键数值与推荐

  • 直肠壁浸润评分:0分无直肠壁信号改变,1分直肠壁水肿/信号改变,2分部分直肠壁浸润,3分全层直肠壁浸润;直肠壁浸润定义为2或3分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Rectal spacers have gained popularity as a dose-sparing material for prostate cancer radiation therapy (RT). However, the procedure can be associated with unintended rectal wall infiltration (RWI) of the spacer gel. We therefore classified RWI severity as a function of depth and explored its association with rectal toxicity using a data set from prostate cancer patients treated with RT on a prospective randomized clinical trial (RCT). METHODS AND MATERIALS: Postimplant T2-weighted magnetic resonance images of 149 subjects randomized to the hydrogel spacer arm of a published multicenter RCT were assessed for the presence and depth of RWI. All implants were assigned a score of 0 (no rectal wall signal changes), 1 (rectal wall edema/signal change), 2 (partial RWI), or 3 (full-thickness RWI); RWI was defined as a score of 2 or 3. Correlations were made between RWI score and physician-reported procedure, acute, and late rectal toxicity. RESULTS: Although 62.4% of implants had no rectal wall signal abnormalities, 24% [scores of 2 (20.1%) and 3 (4.0%)] of procedures exhibited radiographic evidence of RWI. Full-thickness RWI was associated with both a longer length (22.8 ± 7.0 mm, P = .008) and a larger circumferential percentage (35.8% ± 9.2%, P = .045) of rectal infiltration. Although 7 subjects (5%) experienced transient procedure-related rectal toxicities (most commonly perineal/rectal pain), only one had RWI (score of 2, National Cancer Institute's Common Terminology Criteria for Adverse Events grade 1). Consequently, no correlation was observed between procedural rectal toxicity and the presence/extent of RWI (P = .64). Similarly, no difference in acute (P = .64) or late (P = .85) rectal toxicity incidence or grade was detected between RWI categories; none of the 6 men with a RWI score of 3 developed late rectal toxicity by 15 months. CONCLUSIONS: Based on data from an RCT, RWI did not contribute to increased rectal toxicity prior and up to 15 months after conventional prostate cancer RT.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Grossman CE, Akin O, Damato AL, et al. Depth of Hydrogel Spacer Rectal Wall Infiltration Was Not Associated With Rectal Toxicity: Results From a Randomized Prospective Trial. Adv Radiat Oncol. 2024. PMID: 39610659. doi:10.1016/j.adro.2024.101624

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。